D.A. Davidson & CO. Has $5.68 Million Stake in UiPath Inc. (NYSE:PATH)

D.A. Davidson & CO. trimmed its holdings in shares of UiPath Inc. (NYSE:PATH) by 2.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 228,543 shares of the healthcare company’s stock after selling 6,094 shares during the period. D.A. Davidson & CO.’s holdings in UiPath were worth $5,677,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. 180 Wealth Advisors LLC boosted its position in shares of UiPath by 0.3% in the 4th quarter. 180 Wealth Advisors LLC now owns 188,950 shares of the healthcare company’s stock worth $4,497,000 after purchasing an additional 492 shares during the last quarter. Bleakley Financial Group LLC lifted its holdings in shares of UiPath by 4.9% in the fourth quarter. Bleakley Financial Group LLC now owns 12,691 shares of the healthcare company’s stock valued at $315,000 after purchasing an additional 598 shares in the last quarter. Simplicity Solutions LLC lifted its holdings in shares of UiPath by 4.9% in the fourth quarter. Simplicity Solutions LLC now owns 12,691 shares of the healthcare company’s stock valued at $315,000 after purchasing an additional 598 shares in the last quarter. Arizona State Retirement System lifted its holdings in shares of UiPath by 0.8% in the third quarter. Arizona State Retirement System now owns 97,951 shares of the healthcare company’s stock valued at $1,676,000 after purchasing an additional 733 shares in the last quarter. Finally, Axxcess Wealth Management LLC lifted its holdings in shares of UiPath by 2.6% in the third quarter. Axxcess Wealth Management LLC now owns 29,121 shares of the healthcare company’s stock valued at $498,000 after purchasing an additional 740 shares in the last quarter. 62.50% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on PATH. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $29.00 target price on shares of UiPath in a research report on Monday, April 1st. TD Cowen lifted their target price on UiPath from $25.00 to $28.00 and gave the company an “outperform” rating in a research report on Thursday, March 14th. BMO Capital Markets boosted their price target on UiPath from $24.00 to $28.00 and gave the stock a “market perform” rating in a research report on Thursday, March 14th. Needham & Company LLC reissued a “buy” rating and set a $30.00 price target on shares of UiPath in a research report on Wednesday, March 20th. Finally, Truist Financial reissued a “buy” rating and set a $32.00 price target on shares of UiPath in a research report on Wednesday, March 20th. Nine analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, UiPath currently has an average rating of “Moderate Buy” and a consensus price target of $27.41.

Insiders Place Their Bets

In other news, CFO Ashim Gupta sold 40,000 shares of the company’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $19.79, for a total transaction of $791,600.00. Following the completion of the transaction, the chief financial officer now directly owns 946,848 shares in the company, valued at $18,738,121.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders sold 96,000 shares of company stock worth $2,023,440 over the last three months. Insiders own 22.37% of the company’s stock.

UiPath Trading Down 1.6 %

Shares of PATH stock opened at $19.59 on Thursday. The stock has a market cap of $11.15 billion, a P/E ratio of -115.23 and a beta of 1.01. The stock has a 50 day simple moving average of $20.78 and a 200 day simple moving average of $22.07. UiPath Inc. has a 1 year low of $13.30 and a 1 year high of $27.87.

UiPath (NYSE:PATH) last released its earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.10. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. The firm had revenue of $405.25 million during the quarter, compared to analysts’ expectations of $383.32 million. Analysts forecast that UiPath Inc. will post -0.04 EPS for the current year.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.